CYTOSTATIC TREATMENT OF HORMONE-RESISTANT PROSTATIC-CANCER WITH 4-EPIRUBICIN (FARMORUBICIN)

被引：1
|
作者：
HUBMAN, R
HAIDER, A
机构：
[1] Allgemeines Krankenhaus St. Georg, Hamburg
来源：
AKTUELLE UROLOGIE | 1990年 / 21卷
关键词：
D O I：
10.1055/s-2008-1060665
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：18 / 21
页数：4
相关论文
共 50 条
  • [1] FLUTAMIDE IN HORMONE-RESISTANT PROSTATIC-CANCER
    FOSSA, SD
    HOSBACH, G
    PAUS, E
    JOURNAL OF UROLOGY, 1990, 144 (06): : 1411 - 1414
  • [2] AMINOGLUTETHIMIDE IN THE MANAGEMENT OF ADVANCED HORMONE-RESISTANT PROSTATIC-CANCER
    RAGHAVAN, D
    HARNETT, P
    PEARSON, B
    CATERSON, I
    COOREY, GJ
    ROGERS, J
    COATES, A
    BOULAS, J
    BRITISH JOURNAL OF UROLOGY, 1986, 58 (01): : 90 - 90
  • [3] EPIRUBICIN AND MEDROXYPROGESTERONE ACETATE VERSUS ESTRAMUSTINE PHOSPHATE IN HORMONE-RESISTANT PROSTATIC-CANCER - A PROSPECTIVE RANDOMIZED STUDY
    ANDERSTROM, C
    EDDELAND, A
    FOLMERZ, P
    HANSSON, R
    MILLES, S
    ZACHRISSON, B
    EUROPEAN UROLOGY, 1995, 27 (04) : 301 - 305
  • [4] CHEMOTHERAPY OF HORMONE-RESISTANT STAGE-D PROSTATIC-CANCER
    SCHMIDT, JD
    JOURNAL OF UROLOGY, 1980, 123 (06): : 797 - 805
  • [5] LOW-DOSE METHOTREXATE AND DOXORUBICIN IN HORMONE-RESISTANT PROSTATIC-CANCER
    SMITH, MF
    LAWSON, AH
    KIRK, D
    KAYE, SB
    BRITISH JOURNAL OF UROLOGY, 1990, 65 (05): : 513 - 516
  • [6] PHASE-II MULTICENTER STUDY OF EPIRUBICIN FOR HORMONE-RESISTANT PROSTATIC-CANCER WITH MEASURABLE SOFT-TISSUE DISEASE
    TANNOCK, IF
    ERWIN, TJ
    STEWART, DJ
    FONTAINE, B
    GUPTA, S
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (02): : 156 - 158
  • [7] A RANDOMIZED STUDY ON HORMONE-RESISTANT PROSTATIC-CANCER - ESTRAMUSTINE PHOSPHATE VERSUS LOW-DOSE EPIRUBICIN WITH OR WITHOUT MEDROXYPROGESTERONE ACETATE
    TVETER, KJ
    HAGEN, S
    HOLME, I
    KLEPP, O
    KLOSTER, SE
    MURI, O
    POULSEN, C
    SANDER, S
    SIVERTSEN, S
    URNES, T
    OGREID, P
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1990, 24 (04): : 243 - 247
  • [8] FLARE REACTION DURING THE INITIAL TREATMENT PERIOD WITH MEDROXYPROGESTERONE ACETATE IN PATIENTS WITH HORMONE-RESISTANT PROSTATIC-CANCER
    FOSSA, SD
    URNES, T
    EUROPEAN UROLOGY, 1986, 12 (04) : 257 - 259
  • [9] PROSPECTIVE RANDOMIZED MULTICENTRIC PHASE-III STUDY FOR TREATMENT OF HORMONE-REFRACTORY PROSTATIC-CANCER - MITOMYCIN-C VS 4-EPIRUBICIN
    WEISSBACH, L
    UROLOGE-AUSGABE A, 1992, 31 (01): : 62 - 62
  • [10] SEQUENTIALLY ALTERNATING HORMONE CHEMOTHERAPY WITH HIGH-DOSE MEDROXY-PROGESTERONE ACETATE AND LOW-DOSE EPIRUBICIN FOR THE TREATMENT OF HORMONE-RESISTANT METASTATIC PROSTATIC-CANCER
    KONTTURI, M
    SOTARAUTA, M
    TAMMELA, T
    LUKKARINEN, O
    ROMPPAINEN, ML
    GROHN, P
    EUROPEAN UROLOGY, 1988, 15 (1-2) : 43 - 47
12345